Affiliation:
1. Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India
Abstract
Abstract
Pemphigus in pregnancy is a special clinical scenario that has potential consequences on both maternal and fetal outcomes. Being an autoimmune disease with Th2 preponderance, pemphigus is expected to flare in pregnancy, especially in the first two trimesters. Fetal outcomes like stillbirth and neonatal pemphigus have been reported, the latter being a consequence of a transient transplacental transfer of autoantibodies. Management needs to be individualized keeping the risk/benefit ratios of therapies in mind while optimizing maternal and fetal health. It is crucial to have appropriate counseling regarding conception for women with pemphigus in the child-bearing period because the probability of adverse materno-fetal outcomes is higher if the disease is severe.
Reference112 articles.
1. Geographic variations in epidemiology of two autoimmune bullous diseases: Pemphigus and bullous pemphigoid;Alpsoy;Arch Dermatol Res,2015
2. Epidemiology of pemphigus;Kridin;JID Innov,2021
3. Pemphigus in India;Kanwar;Indian J Dermatol Venereol Leprol,2011
4. Pemphigus vulgaris and pregnancy;Mittal;Indian J Dermatol Venereol Leprol,1995
5. Pregnancy associated with pemphigus;Daniel;Br J Obstet Gynaecol,1995
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献